Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
PRIORITY PRESS - 65th Annual Meeting of the Canadian Cardiovascular Society
Effective Event Reduction in the Era of New Oral Anticoagulants: Pursuing Options
Toronto, Ontario / October 27-31, 2012
Toronto - After 50 years of warfarin use for stroke prevention in atrial fibrillation (AF), there are now 3 new oral anticoagulants equal to, or better than warfarin for stroke prevention. Importantly, they are safer than warfarin in terms...
PRIORITY PRESS - 2012 Canadian Hypertension Congress
Optimal Control of Hypertension: From Lifestyle Modifications to Fixed-Dose Combinations
Toronto, Ontario / October 25-28, 2012
Toronto - Over 1000 patients in Canada are diagnosed with hypertension each day. Best treatment plan depends on factors including severity of high blood pressure (BP), age, comorbidities, as well as, patient and physician preference. Common...
PRIORITY PRESS - 2012 Canadian Hypertension Congress
A Template for Improved Blood Pressure Control and Better Adherence: Integrating Third Generation b-blockers and Single-pill Multiple Mechanism Combinations
Toronto, Ontario / October 25-28, 2012
Toronto - For the prevention, diagnosis and treatment of high blood pressure (BP), the Canadian Hypertension Education Program (CHEP) guidelines provide a template against which physicians can tailor antihypertensive regimens according to...
MEDICAL FRONTIERS - 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
Expansion of MS Therapies: Multicentre Phase III Trials of First-Line Oral Agents
Lyon, France / October 10-13, 2012
Lyon - Oral therapies for the control of multiple sclerosis (MS) are poised to proliferate, based on data presented at the 2012 ECTRIMS. Phase III trials have associated several agents with high rates of efficacy both in regard to the risk...
MEDICAL FRONTIERS - 15th Annual Canadian Diabetes Association (CDA)/ Canadian Society of Endocrinology & Metabolism (CSEM) Professional Conference and Annual Meeting
Inhibiting Kidney Glucose Reabsorption: A Novel Insulin-independent Therapy in Type 2 Diabetes Mellitus
Vancouver, BC / October 10-13, 2012
Vancouver - New updated guidelines on the management of type 2 diabetes mellitus are expected early in 2013. A preview of the new guidelines indicates that glycemic targets may be relaxed in select patients and that the individualized...
PRIORITY PRESS - 48th Annual Meeting of the European Association for the Study of Diabetes
Targeting the Kidney in the Treatment of Diabetes and Associated Cardiovascular Risk Factors
Berlin, Germany / October 1-5, 2012
Berlin - Barriers to effective type 2 diabetes mellitus treatment include risk of hypoglycemia and weight gain, which may be associated with an increased risk of mortality and cardiovascular (CV) events. The new class of selective sodium...
ABSTRACTS in PERSPECTIVE - Based on presentations from the 48th Annual Meeting of the European Association for the Study of Diabetes (EASD)
Weighing Benefits of SGLT2 Inhibition in Type 2 Diabetes Mellitus
Berlin, Germany / October 1-5, 2012
EDITORIAL OVERVIEW: David C. W. Lau, MD, PhD, FRCPCEditor-in-Chief, Canadian Journal of DiabetesProfessor of Medicine, Biochemistry & Molecular BiologyJulia McFarlane Diabetes Research CentreUniversity of CalgaryCalgary, AlbertaRonald...
PRIORITY PRESS - 37th European Society of Medical Oncology Congress (ESMO)
Exploring Benefits of Multitargeted Therapy for Metastatic Colorectal Cancer and Gastrointestinal Stromal Tumours
Vienna, Austria / September 28 – October 2, 2012
Vienna - Progress continues to occur in the treatment of metastatic colorectal cancer. Improved recognition of the complexities of tumour signalling networks have led to the realization that inhibition of a single pathway is unlikely to...
PRIORITY PRESS - 21st Congress of the European Academy of Dermatology and Venereology (EADV)
Progress in Advanced Basal-cell Carcinoma: Exploring Hedgehog Pathway Inhibition
Prague, Czech Republic / September 27-30, 2012
Prague - Basal-cell carcinoma (BCC) is the most commonly diagnosed human cancer worldwide. Most BCCs are readily treated by surgery, but some lesions progress to an advanced state (locally advanced BCC) or spread to distant sites...